ScholarIQanswers from OpenAlex

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases

PaperCitations, authors & open-access status

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases have?

ScholarIQcitation count

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases has 254 citations in the OpenAlex counts ScholarIQ stores.

When was Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases published?

ScholarIQyear

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases has 2016 year in the ScholarIQ index.

What is the open-access status of Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases?

ScholarIQoa status

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases has closed oa status in the ScholarIQ index.

What is the DOI of Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases?

ScholarIQdoi

The DOI for Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases is on the source record.

What is the PMID of Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases?

ScholarIQpmid

The PMID for Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases is on the source record.

What is the OpenAlex record for Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases?

ScholarIQopenalex

The OpenAlex for Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial